Pharmaceutical Industry Overview for Q3 2025
The third quarter of 2025 was marked by significant changes in the regulation of the circulation of medical devices, medicinal products, and veterinary medicines in Belarus and across the EAEU. The REVERA Belarus team has prepared an overview summarising the key regulatory updates and clarifications issued by the authorities.
In this overview, you will find:
- draft protocols on the extension of the registration of medical devices under national procedures;
- clarifications from the Centre for Expertise and Testing in Health Care (CEIZ) regarding the transition period for medicinal products following the alignment of registration dossiers with EAEU requirements;
- updated EAEU Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) rules;
- amendments to the National Formulary and lists of medicinal products;
- new rules governing the circulation of veterinary medicines and other related updates.
Read about the key regulatory updates and expert commentary from REVERA specialists via the link below.
Read the articleIf you have any questions or would like to receive individual legal advice, please use the ‘Contact a Lawyer’ button below — our REVERA experts are ready to assist and answer your queries.
Contact a lawyer
Contact a lawyer
